<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0045">
 <label>9</label>
 <element-citation publication-type="journal" id="rf0040">
  <person-group person-group-type="author">
   <name>
    <surname>Demarest</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Underwood</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>St Clair</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Dorey</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Brown</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Zolopa</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Dolutegravir-based regimens are active in integrase Strand transfer inhibitor-naive patients with nucleoside reverse transcriptase inhibitor resistance</article-title>
  <source>AIDS Res Hum Retroviruses</source>
  <volume>34</volume>
  <issue>4</issue>
  <year>2018</year>
  <fpage>343</fpage>
  <lpage>346</lpage>
  <pub-id pub-id-type="pmid">29444582</pub-id>
 </element-citation>
</ref>
